Atlas Trials

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

Clinical trial NCT01241682 · COMPLETED

Trial details

NCT number
NCT01241682
Sponsor
Erasmus Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant (Pleural) Mesothelioma
Start date
2009-10-01
Primary completion
2011-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.